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Importance 
African horse sickness (AHS) is a serious arthropod-borne viral disease of 
equids, with a mortality rate that can reach 95% in some species, such as horses. At 
present, AHS virus (AHSV) is only endemic in Africa; however, suitable vectors exist 
outside this area, and infected animals or vectors may carry the virus into AHS-free 
regions. The potential for dissemination is especially high in animals that tend to 
develop mild or subclinical infections, such as zebras (Equus burchelli) and donkeys, 
or horses with partial immunity. One extensive epidemic in 1959–1961 affected the 
Middle East and parts of Asia, as well as Africa, and is thought to have been 
responsible for the deaths of 300,000 equids. An outbreak in Spain lasted from 1987, 
when the virus was introduced in imported zebras, to 1990, and spread to Portugal 
and Morocco. Within Africa, additional AHSV serotypes have recently spread to 
some areas where only one serotype was previously found. Although vaccines are 
available, cross-protection between serotypes is limited, and the introduction of a new 
serotype into an area may result in outbreaks.  
Etiology 
African horse sickness results from infection with the African horse sickness 
virus (AHSV), a member of the genus Orbivirus in the family Reoviridae. There are 
nine serotypes of this virus, and while some serotypes are cross-protective (e.g., 
serotypes 6 and 9), others are not. 
Species Affected 
Equids including horses, donkeys, mules and zebras are the primary hosts for 
AHSV; however, this virus is also known to affect dogs. Among equids, the most 
serious infections occur in horses and mules, which are thought to be accidental hosts. 
Zebras, which are often asymptomatic, are thought to be the natural reservoir hosts in 
most regions of Africa.  
Antibodies to AHSV have been reported in a number of other species, although 
there are sometimes inconsistencies between studies. Seropositive animals have 
included various wild carnivores, such as hyenas (Crocuta crocuta), jackals (various 
Canis spp.), African wild dogs (Lycaon pictus), cheetahs (Acinonyx jubutus), lions 
(Panthera leo) and large-spotted genets (Genetta maculata), which might be exposed 
by feeding on infected zebras. Some authors have reported that carnivores may have 
antibodies to AHSV serotypes (e.g., serotype 4) that are not necessarily common 
among equids in the area. There are also reports of seropositive herbivores including 
dromedary camels (Camelus dromedarius), sheep, goats, African elephants 
(Loxodonta africana), black rhinocerus (Diceros bicornis) and white rhinocerus 
(Ceratotherium simum). Attempts to establish experimental infections resulted in 
seroconversion with no evidence of virus replication in African elephants, and 
seroconversion in hyenas, while mink (Mustela vison) did not seroconvert or replicate 
virus. The significance of seropositive animals is still unclear, and no animals other 
than equids are thought to be important in maintaining or amplifying AHSV. 
Zoonotic potential 
African horse sickness is not zoonotic. 
Geographic Distribution 
African horse sickness is endemic in sub-Saharan Africa. Serotype 9 is 
widespread in the endemic region, while serotypes 1 to 8 occur in limited areas. The 
greatest virus diversity has been reported in southern and eastern Africa. Some 
serotypes have recently caused outbreaks in countries where they were not previously 
found. In particular, serotypes such as 2, 4, 6, 7 and 8 have been detected in regions 
where only serotype 9 was once common.  
African horse sickness outbreaks have occurred outside Africa in the Middle 
East, the Mediterranean region of Europe and parts of Asia (e.g., the Indian 
subcontinent). Although all outbreaks, to date, were eventually eradicated, AHSV was 
able to persist for years in some areas. 
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Transmission 
AHSV is transmitted by the midges Culicoides imicola 
and C. bolitinos in Africa. Additional species of Culicoides 
might also be able to act as vectors. They include species 
found outside the endemic region, such as C. variipennis, 
which occurs in North America and is an efficient AHSV 
vector in the laboratory, and C. brevitarsis, which is common 
in Australia. Wind has been implicated in the dispersal of 
infected vectors during some epidemics. AHSV is capable of 
overwintering, at least in milder climates where Culicoides 
adults can survive. Other arthropods might also be capable of 
transmitting AHSV, but are thought to be, at most, only 
minor sources of infection. Mosquitoes have been implicated 
as possible biological vectors, and biting flies in the genera 
Stomoxys and Tabanus may be able to transmit the virus 
mechanically. AHS virus was also isolated from the camel 
tick Hyalomma dromedarii in Egypt, and the dog tick, 
Rhipicephalus sanguineus, could transmit AHSV from dogs 
in the laboratory.  
Zebras are thought to be the natural reservoir hosts for 
AHSV, but horses, mules and donkeys can also develop 
viremia sufficient to infect Culicoides. How long equids 
remain infectious for the vector is not certain; however, 
AHSV could be isolated from the blood of some 
experimentally infected zebras for up to 40 days, and from 
the spleen at 48 days. In experimentally infected horses, 
this virus has been recovered from blood for as long as 21 
days, although viremia typically lasts only 4-8 days. 
Donkeys are reported to remain viremic for up to 28 days, 
and viral RNA has been detected longer in some studies 
(e.g., 47 days or more in some experimentally infected 
animals inoculated with serotype 4). African horse sickness 
is not transmitted between equids by casual contact. 
Dogs can be infected if they eat contaminated 
horsemeat, and experimental infections have been established 
by the oral route as well as by subcutaneous or intravenous 
inoculation. AHSV is reported to persist for some time in 
frozen meat, and it is reported to survive for up to 6 months 
at 4ºC in medium containing serum, and for more than 2 
years in putrid blood. Although arthropods including ticks 
can transmit AHSV from dogs to other dogs or horses in the 
laboratory, viremia is usually low and transient, and dogs are 
not thought to be significant in the epidemiology of African 
horse sickness. In addition, dogs are not usually hosts for 
Culicoides in the endemic region. 
Disinfection 
AHSV can be inactivated in the laboratory with 
formalin, -propriolactone, acetylethyleneimine derivatives 
or radiation. It is resistant to liquid solvents such as ether. It 
is also destroyed at pH < 6 or pH ≥ 12. Acidic disinfectants 
such as 2% acetic or citric acid have been recommended for 
decontamination when it is warranted. AHSV is relatively 
heat stable, and it was not inactivated by heating in citrated 
plasma at 55-75°C for 10 minutes. 
Incubation Period 
The incubation period for African horse sickness in equids 
is approximately 3 days to 2 weeks (usually < 9 days), with 
the cardiac form typically developing later than the 
pulmonary form. Experimental infections suggest that the 
incubation period is potentially be as long as 21 days. 
Clinical Signs 
Four different forms of African horse sickness exist: 
the peracute (pulmonary) form, the subacute edematous 
(cardiac) form, the acute (mixed) form, and horsesickness 
fever. Sudden death can also occur without preceding signs. 
Symptomatic infections are seen most often in horses and 
mules, with the pulmonary and mixed forms usually 
predominating in susceptible populations of horses. Zebras 
and donkeys rarely develop serious clinical signs. The 
mildest form, horsesickness fever, tends to develop in 
resistant species such as donkeys, or in horses with partial 
immunity. This form can also occur in zebras, although 
most infections in this species are asymptomatic. 
The peracute or pulmonary form 
The pulmonary form of African horse sickness usually 
begins with an acute fever, followed within a day or two by 
the sudden onset of severe respiratory distress. Animals 
with this form often stand with forelegs spread, head 
extended, and nostrils fully dilated. Other clinical signs may 
include tachypnea, forced expiration, profuse sweating, 
spasmodic coughing, and a frothy serofibrinous nasal 
exudate. Dyspnea usually progresses rapidly, and the 
animal often dies within a few hours after the respiratory 
signs appear.  
The subacute edematous or cardiac form 
The cardiac form of African horse sickness usually 
begins with a fever that lasts less than a week. Shortly 
before the fever starts to subside, edematous swellings 
appear in the supraorbital fossae and eyelids. These 
swellings later spread to involve the face, tongue, 
intermandibular space, laryngeal region, and sometimes the 
neck, shoulders and chest. Edema of the lower legs is 
absent. Other clinical signs, usually seen in the terminal 
stages of the disease, can include severe depression, colic, 
petechiae or ecchymoses on the ventral surface of the 
tongue, and petechiae in the conjunctivae. Death often 
occurs from cardiac failure. If the animal recovers, the 
swellings gradually subside over a few days to a week. 
The acute or mixed form 
Clinical signs of both the pulmonary and cardiac forms 
are seen in the mixed form. In most cases, the cardiac form 
is subclinical and is followed by severe respiratory distress. 
Occasionally, mild respiratory signs may be followed by 
edema and death from cardiac failure. Although the mixed 
form is common, it may not be recognized except at 
necropsy. 
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Horsesickness fever 
Horsesickness fever is characterized mainly by fever, 
often with morning remissions and afternoon exacerbations. 
Other signs are generally mild and may include mild 
anorexia or depression, edema of the supraorbital fossae, 
congested mucous membranes and an increased heart rate. 
Death would be unusual. 
Infections in dogs 
The pulmonary form is reported to be the most 
common form in dogs. Fatal cases have been described in 
dogs that ate infected meat during epidemics. In one 
outbreak, 13 of 17 dogs died with unspecified clinical signs, 
while two animals that survived longer had fever, 
depression, dyspnea, moist rales and white foam around the 
nostrils, and died within 24 hours despite intensive care. 
Some dogs living in endemic regions are seropositive, 
suggesting that milder cases or subclinical infections also 
occur, and AHSV has been isolated from feral dogs not 
reported to be ill. In early experiments, which used crude 
preparations of virus (e.g., filtered blood from infected 
horses), some dogs had no apparent signs of illness, while 
others developed febrile reactions and survived, or died 
with evidence of severe pulmonary disease.  
Post Mortem Lesions      Click to view images 
Equids 
In the pulmonary form of African horse sickness, the 
characteristic lesions are interlobular edema of the lungs 
and hydrothorax. In the most acute cases, frothy fluid is 
present in the trachea and pulmonary airways, and may 
flow from the nostrils and the cut surface of the lungs. The 
lungs are typically mottled red (with distended interlobular 
septae) noncollapsed and heavy. In more prolonged cases, 
there may be extensive interstitial and subpleural edema, 
and hyperemia may be less apparent. Fluid may be found in 
the thoracic cavity (hydrothorax) and abdominal cavity. 
Occasionally, there can be extensive fluid accumulation in 
the thoracic cavity, with near normal appearance of the 
lungs. The lymph nodes, particularly the nodes in the 
thoracic and abdominal cavities, are usually enlarged and 
edematous. In some cases, there may also be subcapsular 
hemorrhages in the spleen, congestion in the renal cortex, 
edematous infiltration around the aorta and trachea, and 
petechial hemorrhages on various serosal and pleural 
surfaces. Gastrointestinal lesions can include hyperemia 
and petechiae in the small and large intestines, and 
hyperemia of the gastric fundus. Cardiac lesions are not 
prominent, although petechiae may be found on the 
pericardium, and there may be increased pericardial fluid. 
In the cardiac form, a yellow gelatinous infiltrate can 
be seen in the subcutaneous and intermuscular fascia of the 
head, neck and shoulders, and occasionally the brisket, 
ventral abdomen and rump. Hydropericardium is common. 
The epicardium and endocardium often contain petechial 
and ecchymotic hemorrhages. Lesions may also be found in 
the gastrointestinal tract, resembling the pulmonary form. 
In addition, prominent submucosal edema may be noted in 
the cecum, large colon and rectum. Ascites can also be 
seen. The lungs are usually normal or slightly 
edematous/engorged in this form of AHS, and the thoracic 
cavity rarely contains excess fluid. 
In the mixed form, the post-mortem lesions are a 
mixture of typical findings from both the cardiac and 
pulmonary forms.  
Dogs 
The gross lesions reported in dogs have been consistent 
with pulmonary disease; the main lesions were hydrothorax 
and pulmonary congestion and edema. Red-tinged foam 
was noted in the airways of some animals. In some cases, 
the fluid in the lungs (clear and straw-colored) gelled on 
exposure to the air. Areas of emphysema and/or areas of 
hepatization were also reported in some lungs. Other 
lesions, such as hyperemia of the intestinal mucosa, 
petechiae and ecchymoses on the endocardium, and 
congestion of the liver and other internal organs have been 
noted in experimentally infected or naturally infected dogs.  
Diagnostic Tests 
African horse sickness is often diagnosed by 
virological methods. More than one test should be used to 
diagnose an outbreak (particularly the index case) whenever 
possible. AHSV can be isolated from the blood of live 
animals, or from tissue samples, especially spleen, lung and 
lymph nodes, collected at necropsy. Successful isolation 
from the blood is most likely if these samples are collected 
early during the febrile stage. AHSV can be recovered in 
various cell lines including baby hamster kidney (BHK-21), 
monkey stable (MS) or African green monkey kidney 
(Vero) cells, as well as Culicoides (e.g., KC cells) and 
mosquito insect cell lines, and in embryonated eggs, 
Intracerebral inoculation of newborn mice can also be 
performed. The isolate should be serotyped using virus 
neutralization or other methods, to allow the selection of an 
appropriate vaccine strain.  
AHSV antigens can be detected in the blood and 
tissues (e.g., spleen) with enzyme-linked immunosorbent 
assays (ELISAs). Various reverse-transcription polymerase 
chain reaction (RT-PCR) assays are used to detect viral 
RNA. Some RT-PCR assays can also be used for rapid 
serotyping of field isolates. 
Serology can also be used to diagnose African horse 
sickness, with antibodies usually detected within 8 to 14 
days after infection. Paired serum samples are 
recommended, and are particularly important in areas where 
the disease is endemic. Available serologic tests include 
ELISAs, complement fixation, immunoblotting and virus 
neutralization. Complement fixation is now used 
infrequently in many areas, although is still employed in 
some endemic regions. The virus neutralization test is used 
for serotyping. Immunodiffusion and hemagglutination 
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inhibition tests have also been described. Cross-reactivity 
between AHSV serotypes is variable, and AHSV does not 
cross-react with other known orbiviruses.  
Treatment 
There is no specific treatment for African horse 
sickness, other than supportive care. Treatment may also be 
needed for secondary infections. 
Control 
Disease reporting 
A quick response is vital for containing outbreaks in 
AHS-free regions. Veterinarians who encounter or suspect 
this disease should follow their national and/or local 
guidelines for disease reporting. In the U.S., state or federal 
veterinary authorities should be informed immediately. 
Prevention 
Live attenuated vaccines are routinely used to control 
African horse sickness in endemic regions. Monovalent or 
polyvalent vaccines may be employed, depending on the 
viruses circulating in the area. Reactivity to some vaccine 
strains is reported to be better than to others, and protection 
may be incomplete in some cases: clinical cases and mild or 
subclinical infections have been reported in some horses that 
had received as many as 5 vaccine doses in Africa. The 
currently available vaccines are teratogenic in pregnant 
mares, and vaccine strains may be transmitted by Culicoides 
vectors. No killed or subunit vaccines are currently 
manufactured commercially.  
Stabling equids in insect-proof housing, especially 
from dusk to dawn (when Culicoides are most active), can 
also reduce the risk of infection. One study suggested that 
open stables might provide some degree of protection from 
C. imicola, but did not protect horses from C. bolitinos. 
Instead, concentrations of the latter vector seemed to 
increase inside open stables that contained horses. Vector 
control measures such as insect repellents and targeted 
applications of insecticides or larvicides might also be 
helpful.  
When outbreaks occur in endemic areas, they have 
generally been controlled by vaccination and movement 
restrictions on equids. Some authors have recommended 
that surveillance systems be established to provide early 
warnings of outbreaks and detect the introduction of new 
serotypes in an area. Donkeys, which are not usually 
vaccinated for AHS, might be monitored by serology.  
Most non-endemic countries test and quarantine 
imported equids to prevent them from introducing AHSV. 
The quarantine period may be extensive (e.g., 60 days in 
the U.S., if the horse is from an endemic country). If a virus 
is introduced into a non-endemic region, control measures 
may include the establishment of quarantine zones and 
movement controls, vaccination campaigns, and possibly 
the euthanasia of infected animals, depending on the 
situation. Stabling equids in insect-proof housing, at least 
overnight, can provide some protection to uninfected 
animals, as well as reduce the risk that infected animals will 
transmit the virus to vectors. Vector control measures may 
reduce the number of Culicoides, although they are unlikely 
to be completely eliminated. Monitoring for fever can be 
helpful in detecting cases early. Each susceptible animal 
should have its temperature taken regularly (optimally, 
twice daily). The onset of cold weather can end epidemics, 
but the virus has sometimes re-emerged in the spring, at 
least in climates with mild winters (e.g., in Spain). 
Morbidity and Mortality 
Significant numbers of equids in Africa (e.g., 34% of 
equids and up to 50% of donkeys in Ethiopia) have been 
exposed to AHSV. Antibodies have also been documented in 
other animals, including 4-8% of dogs in some areas, 
although the significance of this finding is still unclear. 
Outbreaks of African horse sickness tend to occur in late 
summer and autumn, with cycles occurring at irregular 
intervals in some regions. Climatic conditions reported to 
favor epidemics are heavy rain alternating with hot, dry 
periods. Some countries have reported that there are fewer 
outbreaks since the number of free-ranging wild zebras 
decreased. In other regions, African horse sickness outbreaks 
seem to have increased recently, and have sometimes been 
caused by serotypes not usually found in that area.   
Morbidity and mortality differ, depending on the viral 
strain, species of animal, previous immunity and form of the 
disease. In horses that develop clinical signs, the pulmonary 
form of African horse sickness is nearly always fatal, and the 
mortality rate in the cardiac form is usually 50% or higher. In 
the mixed form, mortality rate estimates vary from 
approximately 70% to greater than 80%, while horsesickness 
fever is not fatal. The mixed and pulmonary forms tend to 
predominate in naive horse populations, and the mortality 
rate is usually 50-95%. African horse sickness is generally 
less severe in other equids. The mortality rate is 
approximately 50% in mules during epidemics, and 5-10% in 
European and Asian donkeys. Deaths are rare among 
donkeys and zebra in endemic areas of Africa. Little is 
known about morbidity and mortality rates in dogs, but both 
subclinical and fatal infections have been reported. Once 
pulmonary signs appear, the prognosis in this species also 
appears to be poor. In one outbreak, 15 of 17 dogs died after 
being fed horsemeat from a sick horse. Intensive treatment 
was attempted in 2 of these animals, but it was unsuccessful. 
Equids that recover from African horse sickness 
develop good immunity to the infecting serotype and partial 
immunity to other serotypes.  
Public Health 
Humans are not natural hosts for the African horse sickness 
virus, and no cases have been seen after contact with field 
strains. However, a neurotropic vaccine strain, adapted to mice, 
can cause encephalitis and retinitis in humans. 
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Internet Resources 
The Merck Veterinary Manual 
http://www.merckmanuals.com/vet/index.html  
United States Animal Health Association.  
Foreign Animal Diseases 
http://www.aphis.usda.gov/emergency_response/downl
oads/nahems/fad.pdf 
World Organization for Animal Health (OIE) 
http://www.oie.int/  
OIE Manual of Diagnostic Tests and Vaccines for  
Terrestrial Animals  
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/ 
OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/ 
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